CAPTRUST Financial Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7K | Sell |
11,842
-4,103
| -26% | -$4.76K | ﹤0.01% | 2486 |
|
|
2025
Q1 | $25.4K | Buy |
15,945
+5,162
| +48% | +$8.21K | ﹤0.01% | 2312 |
|
|
2024
Q4 | $32.7K | Buy |
+10,783
| New | +$32.7K | ﹤0.01% | 2260 |
|
|
2022
Q3 | – | Sell |
-750
| Closed | -$21K | – | 4136 |
|
|
2022
Q2 | $21K | Sell |
750
-13
| -2% | -$364 | ﹤0.01% | 3353 |
|
|
2022
Q1 | $35K | Buy |
763
+758
| +15,160% | +$34.8K | ﹤0.01% | 3051 |
|
|
2021
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 4943 |
|
|
2021
Q1 | – | Sell |
-385
| Closed | -$20K | – | 4493 |
|
|
2020
Q4 | $20K | Buy |
+385
| New | +$20K | ﹤0.01% | 2259 |
|